Provided by Tiger Trade Technology Pte. Ltd.

Insulet

208.22
-9.8900-4.53%
Pre-market: 210.171.95+0.94%04:02 EDT
Volume:893.11K
Turnover:187.41M
Market Cap:14.65B
PE:59.85
High:218.05
Open:216.83
Low:208.14
Close:218.11
52wk High:354.88
52wk Low:208.14
Shares:70.35M
Float Shares:70.08M
Volume Ratio:1.01
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.48
EPS(LYR):3.48
ROE:18.12%
ROA:9.43%
PB:9.67
PE(LYR):59.85

Loading ...

Barclays Adjusts Price Target on Insulet to $301 From $300, Maintains Equalweight Rating

MT Newswires Live
·
Nov 05, 2025

Barclays Sticks to Their Hold Rating for Insulet (PODD)

TIPRANKS
·
Nov 05, 2025

Insulet Corporation Files Initial Statement of Beneficial Ownership for Director Robert Luther Huffines

Reuters
·
Nov 04, 2025

Insulet Corp. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Nov 04, 2025

Insulet Corp. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Oct 30, 2025

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 28, 2025

Insulet’s Omnipod 5 Study: A Real-World Evaluation of Diabetes Management

TIPRANKS
·
Oct 28, 2025

1 Safe-and-Steady Stock to Own for Decades and 2 We Brush Off

stock_story_highlight
·
Oct 27, 2025

Insulet Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Oct 24, 2025

Insulet (PODD) Valuation in Focus After Board Addition and Upbeat Analyst Upgrades

Simply Wall St.
·
Oct 24, 2025

Insulet Appoints Robbie Huffines as New Director

TIPRANKS
·
Oct 23, 2025

Insulet Appoints Robert L. Huffines to Board of Directors

Reuters
·
Oct 23, 2025

Insulet Announces Appointment of Robert L. Huffines to Its Board of Directors

THOMSON REUTERS
·
Oct 23, 2025

Insulet Corp : Stifel Resumes Coverage With Buy Rating; Price Target $370

THOMSON REUTERS
·
Oct 21, 2025

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 21, 2025

Leerink Partners Keeps Their Buy Rating on Insulet (PODD)

TIPRANKS
·
Oct 16, 2025

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Oct 15, 2025

Will Insulet’s (PODD) Innovation Roadmap Reinforce Its Competitive Edge in Diabetes Technology?

Simply Wall St.
·
Oct 15, 2025

Leerink Partners Adjusts Price Target on Insulet to $355 From $339, Maintains Outperform Rating

MT Newswires Live
·
Oct 14, 2025

Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events

GlobeNewswire
·
Oct 13, 2025